Perspectives of Neuro-COVID: Myasthenia

Overview

Journal Front Neurol

Specialty Neurology

Date 2021 Mar 18

PMID 33732209

Citations 6

Authors

Josef Finsterer

Fulvio A Scorza

Affiliations

Soon will be listed here.

Citing Articles

Predictive Factors for Poor Outcomes Associated with COVID-19 in a Retrospective Cohort of Myasthenia Gravis Patients.

Bi Z, Gao H, Lin J, Gui M, Li Y, Li Z J Inflamm Res. 2024; 17:5807-5820.

PMID: 39224657 PMC: 11368097. DOI: 10.2147/JIR.S475729.

Autoimmune myasthenia gravis and COVID-19. A case report-based review.

Croitoru C, Cuciureanu D, Hodorog D, Grosu C, Cianga P J Int Med Res. 2023; 51(8):3000605231191025.

PMID: 37565671 PMC: 10422912. DOI: 10.1177/03000605231191025.

The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline.

Carlson E, Macsai M, Bertrand S, Bertrand D, Nau J Int J Mol Sci. 2023; 24(6).

PMID: 36982671 PMC: 10051900. DOI: 10.3390/ijms24065597.

Not the Virus but Treatment and Immune Response Cause SARS-CoV-2-associated Neuropathy.

Finsterer J Indian J Crit Care Med. 2022; 26(8):980.

PMID: 36042769 PMC: 9363799. DOI: 10.5005/jp-journals-10071-23849.

The relationship between myasthenia gravis and COVID-19: a systematic review.

Tugasworo D, Kurnianto A, Retnaningsih , Andhitara Y, Ardhini R, Budiman J Egypt J Neurol Psychiatr Neurosurg. 2022; 58(1):83.

PMID: 35818475 PMC: 9261189. DOI: 10.1186/s41983-022-00516-3.

References

Scoppetta C, Casciato S, Di Gennaro G . Speculative clues on Myasthenia gravis and COVID-19. Eur Rev Med Pharmacol Sci. 2020; 24(15):7925-7926. DOI: 10.26355/eurrev_202008_22474. View

Grifoni E, Valoriani A, Cei F, Vannucchi V, Moroni F, Pelagatti L . The CALL Score for Predicting Outcomes in Patients With COVID-19. Clin Infect Dis. 2020; 72(1):182-183. PMC: 7314186. DOI: 10.1093/cid/ciaa686. View

Finsterer J, Scorza F, Scorza C . Diagnosing myasthenic crisis in SARS-CoV-2 infected patients requires adherence to appropriate criteria. J Neurol Sci. 2020; 417:117062. PMC: 7384431. DOI: 10.1016/j.jns.2020.117062. View

Nakamura M, Nakashima I . [Treatment of Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder and Myasthenia Gravis during the COVID-19 Pandemic]. Brain Nerve. 2020; 72(10):1079-1083. DOI: 10.11477/mf.1416201652. View

Anand P, Slama M, Kaku M, Ong C, Cervantes-Arslanian A, Zhou L . COVID-19 in patients with myasthenia gravis. Muscle Nerve. 2020; 62(2):254-258. PMC: 7272991. DOI: 10.1002/mus.26918. View

Huber M, Rogozinski S, Puppe W, Framme C, Hoglinger G, Hufendiek K . Postinfectious Onset of Myasthenia Gravis in a COVID-19 Patient. Front Neurol. 2020; 11:576153. PMC: 7573137. DOI: 10.3389/fneur.2020.576153. View

Delly F, Syed M, Lisak R, Zutshi D . Myasthenic crisis in COVID-19. J Neurol Sci. 2020; 414:116888. PMC: 7200364. DOI: 10.1016/j.jns.2020.116888. View

Muppidi S, Guptill J, Jacob S, Li Y, Farrugia M, Guidon A . COVID-19-associated risks and effects in myasthenia gravis (CARE-MG). Lancet Neurol. 2020; 19(12):970-971. PMC: 7837033. DOI: 10.1016/S1474-4422(20)30413-0. View

Hubers A, Lascano A, Lalive P . Management of patients with generalised myasthenia gravis and COVID-19: four case reports. J Neurol Neurosurg Psychiatry. 2020; 91(10):1124-1125. DOI: 10.1136/jnnp-2020-323565. View

10.

Koc G, Odabasi Z, Tan E . Myasthenic Syndrome Caused by Hydroxychloroquine Used for COVID-19 Prophylaxis. J Clin Neuromuscul Dis. 2020; 22(1):60-62. DOI: 10.1097/CND.0000000000000316. View

11.

Finsterer J, Scorza F, Scorza C, Fiorini A . SARS-CoV-2 and myasthenia. J Med Virol. 2020; 93(7):4133-4135. DOI: 10.1002/jmv.26501. View

12.

Rein N, Haham N, Orenbuch-Harroch E, Romain M, Argov Z, Vaknin-Dembinsky A . Description of 3 patients with myasthenia gravis and COVID-19. J Neurol Sci. 2020; 417:117053. PMC: 7832365. DOI: 10.1016/j.jns.2020.117053. View

13.

Wang A, Quintero Cardona O, Ho D, Busque S, Lenihan C . Influence of immunosuppression on seroconversion against SARS-CoV-2 in two kidney transplant recipients. Transpl Infect Dis. 2020; 23(1):e13423. PMC: 7404350. DOI: 10.1111/tid.13423. View

14.

Moschella P, Roth P . Isolated COVID-19 Infection Precipitates Myasthenia Gravis Crisis: A Case Report. Clin Pract Cases Emerg Med. 2020; 4(4):524-526. PMC: 7676765. DOI: 10.5811/cpcem.2020.9.49049. View

15.

Jallouli M, Saadoun D, Eymard B, Leroux G, Haroche J, Le Thi Huong D . The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature. J Neurol. 2011; 259(7):1290-7. DOI: 10.1007/s00415-011-6335-z. View

16.

Ghasemiyeh P, Borhani-Haghighi A, Karimzadeh I, Mohammadi-Samani S, Vazin A, Safari A . Major Neurologic Adverse Drug Reactions, Potential Drug-Drug Interactions and Pharmacokinetic Aspects of Drugs Used in COVID-19 Patients with Stroke: A Narrative Review. Ther Clin Risk Manag. 2020; 16:595-605. PMC: 7335700. DOI: 10.2147/TCRM.S259152. View

17.

Hoang P, Hurtubise B, Muppidi S . Clinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infection. Neurology. 2020; 95(18):840-843. DOI: 10.1212/WNL.0000000000010651. View

18.

Varan O, Kucuk H, Tufan A . Myasthenia gravis due to hydroxychloroquine. Reumatismo. 2016; 67(3):849. DOI: 10.4081/reumatismo.2015.849. View

19.

Teng C, Baus C, Wilson J, Frei C . Rhabdomyolysis Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS). Int J Med Sci. 2019; 16(11):1504-1509. PMC: 6818202. DOI: 10.7150/ijms.38605. View

20.

Sriwastava S, Tandon M, Kataria S, Daimee M, Sultan S . New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review. J Neurol. 2020; 268(8):2690-2696. PMC: 7549728. DOI: 10.1007/s00415-020-10263-1. View